Quick Answer
Dianthus Therapeutics, Inc. /DE/ reported Total Assets of $530.92 million for fiscal year 2025.
Dianthus Therapeutics, Inc. /DE/ Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $530.92M | +42.0% |
| 2024 | $374.01M | +108.5% |
| 2023 | $179.41M | +115.9% |
| 2022 | $83.11M | -56.2% |
| 2021 | $189.93M | +17.5% |
| 2020 | $161.62M | +0.1% |
| 2019 | $161.51M | +2.7% |
| 2018 | $157.31M | +188.8% |
| 2017 | $54.46M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $577.45M | +63.0% | +77.1% |
| June 30, 2025 | $326.08M | -11.6% | -6.5% |
| March 31, 2025 | $348.58M | -8.9% | -6.8% |
| December 31, 2024 | $374.01M | +108.5% | +5.6% |
| September 30, 2024 | $354.25M | +84.1% | -4.0% |
| June 30, 2024 | $368.96M | +369.2% | -3.5% |
| March 31, 2024 | $382.46M | +358.4% | +113.2% |
| December 31, 2023 | $179.41M | +115.9% | -6.8% |
- Dianthus Therapeutics, Inc. /DE/ showed an increase of +42.0% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Dianthus Therapeutics, Inc. /DE/’s total assets has grown by 874.8% (from $54.46 million to $530.92 million).
- The most recent figure is from Dianthus Therapeutics, Inc. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: